TourniTek

TourniTek is a medical device company developing a pre-hospital treatment for severe limb injuries to prevent amputation. Founded in March 2017 by Logan Jacobs (CEO) and Dr. Shahram Aarabi (Chief Science Officer), the Seattle-based firm aims to set a new standard in trauma care. Jacobs has a background in finance and economics, while Dr. Aarabi is a surgeon with fellowships in surgical critical care, trauma, and vascular surgery, holding a Master's in Public Health from Harvard University.

The company's core product combines the functions of a traditional tourniquet with therapeutic cooling. This approach is designed to preserve the injured limb by lowering its core temperature, which substantially extends the viable time window for transport and surgical intervention, thereby preventing amputation and long-term disability. The device addresses the shortcomings of standard tourniquets, which can lead to tissue damage or amputation if applied for the prolonged periods often required in military or remote civilian evacuations.

TourniTek operates in the medical devices and equipment industry, with a significant focus on the defense and military market. The company's business model appears to be driven by research, development, and government contracting. TourniTek has secured significant funding through contracts with the U.S. Air Force to develop its technology. The company has partnered with both the U.S. and Canadian militaries for testing and has multiple patents pending for its technology.

Keywords: pre-hospital treatment, limb preservation, therapeutic cooling, amputation prevention, trauma care, medical device, tourniquet, emergency medicine, military medicine, field surgery, hemorrhage control, vascular injury, trauma innovation, defense contracting, surgical instruments